Last reviewed · How we verify
Azienda Ospedaliero-Universitaria di Modena — Portfolio Competitive Intelligence Brief
3 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Recombinant LH (Luveris) | Recombinant LH (Luveris) | marketed | Gonadotropin; recombinant hormone | Luteinizing hormone receptor (LHCGR) | Reproductive endocrinology; Fertility | |
| Pain killer | Pain killer | marketed | ||||
| peritoneal dialysate at 37°C temperature | peritoneal dialysate at 37°C temperature | marketed | Renal replacement therapy solution | Nephrology | ||
| No Treatment Added | No Treatment Added | phase 3 |
Therapeutic area mix
- Nephrology · 1
- Reproductive endocrinology; Fertility · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Instituto de Investigacion Sanitaria La Fe · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Azienda Ospedaliero-Universitaria di Modena:
- Azienda Ospedaliero-Universitaria di Modena pipeline updates — RSS
- Azienda Ospedaliero-Universitaria di Modena pipeline updates — Atom
- Azienda Ospedaliero-Universitaria di Modena pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Azienda Ospedaliero-Universitaria di Modena — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azienda-ospedaliero-universitaria-di-modena. Accessed 2026-05-17.